These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 7573116)
1. Correlates of insulin autoantibodies with beta cell function at the time of diagnosis of diabetes mellitus. al-Attas OS Am J Med Sci; 1995 Oct; 310(4):138-42. PubMed ID: 7573116 [TBL] [Abstract][Full Text] [Related]
2. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group. Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390 [TBL] [Abstract][Full Text] [Related]
3. Role of beta-cell autoantibodies as a predictor marker in diabetic patients and their relationship to glycemic control. Ali NA; Swelam E; AI Banna EA; Showkry A Egypt J Immunol; 2012; 19(1):39-49. PubMed ID: 23888550 [TBL] [Abstract][Full Text] [Related]
4. Residual pancreatic function in insulin dependent diabetics. Glatthaar C; Beaven DW; Donald RA; Smith JR; Espiner EA Aust N Z J Med; 1982 Feb; 12(1):43-7. PubMed ID: 7044357 [TBL] [Abstract][Full Text] [Related]
5. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group. Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon. Hendriksen C; Faber OK; Drejer J; Binder C Diabetologia; 1977 Dec; 13(6):615-9. PubMed ID: 338408 [TBL] [Abstract][Full Text] [Related]
7. Frequency of insulin-dependent diabetes mellitus in Turkish adult-onset diabetic population. Gürlek A; Erbaş T; Sayinalp S; Gedik O Acta Diabetol; 1996 Sep; 33(3):216-9. PubMed ID: 8904928 [TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset. Rattarasarn C; Diosdado MA Horm Metab Res; 1999 May; 31(5):311-6. PubMed ID: 10422726 [TBL] [Abstract][Full Text] [Related]
9. [Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells]. Szepietowska B; Szelachowska M; Górska M; Jakubczyk D; Kinalska I Pol Arch Med Wewn; 2004 May; 111(5):563-9. PubMed ID: 15508807 [TBL] [Abstract][Full Text] [Related]
10. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency. Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306 [TBL] [Abstract][Full Text] [Related]
11. Predictive value of insulin autoantibodies for further progression of beta cell dysfunction in non-insulin-dependent diabetics. Nakanishi K; Kobayashi T; Sugimoto T; Murase T; Itoh T; Kosaka K Diabetes Res; 1988 Nov; 9(3):105-9. PubMed ID: 3072143 [TBL] [Abstract][Full Text] [Related]
12. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. Faber OK; Binder C Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604 [TBL] [Abstract][Full Text] [Related]
13. Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Røder ME; Dinesen B; Hartling SG; Houssa P; Vestergaard H; Sodoyez-Goffaux F; Binder C Diabetes Care; 1999 Apr; 22(4):609-14. PubMed ID: 10189540 [TBL] [Abstract][Full Text] [Related]
15. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Schloot NC; Roep BO; Wegmann D; Yu L; Chase HP; Wang T; Eisenbarth GS Diabetologia; 1997 May; 40(5):564-72. PubMed ID: 9165225 [TBL] [Abstract][Full Text] [Related]
16. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection. Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518 [TBL] [Abstract][Full Text] [Related]
17. [C-peptide, IgG-insulin antibodies, island cell antibodies and immune response genes in diabetes mellitus]. Schernthaner G; Ludwig H; Mayr WR Verh Dtsch Ges Inn Med; 1978; (84):1200-4. PubMed ID: 105488 [No Abstract] [Full Text] [Related]
18. [Determination of plasmatic C-peptide and its clinical uses]. Cautela G; Barbero PL; Gamba S; Regis G; Bruni B Ann Osp Maria Vittoria Torino; 1978; 21(7-12):203-37. PubMed ID: 399164 [TBL] [Abstract][Full Text] [Related]
19. Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus. Gjessing HJ; Damsgaard EM; Matzen LE; Frøland A; Faber OK Diabetes Care; 1987; 10(5):558-62. PubMed ID: 3315512 [TBL] [Abstract][Full Text] [Related]
20. A simplified method to assess affinity of insulin autoantibodies. Achenbach P; Guo LH; Gick C; Adler K; Krause S; Bonifacio E; Colman PG; Ziegler AG Clin Immunol; 2010 Dec; 137(3):415-21. PubMed ID: 20920845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]